In a groundbreaking study published in Cell Biomaterials, researchers at the University of California San Diego have uncovered the remarkable potential of the cowpea mosaic virus (CPMV) in harnessing the body’s immune system to target and eliminate cancer cells. Unlike other plant viruses, CPMV has shown exceptional efficacy in activating a robust anti-tumor response in preclinical studies involving mouse models and even canine cancer patients.
By directly injecting CPMV into tumors, researchers have observed the recruitment of innate immune cells, such as neutrophils, macrophages, and natural killer cells, to effectively destroy cancer cells within the tumor microenvironment. Additionally, CPMV therapy triggers the activation of B cells and T cells, leading to the establishment of a systemic, enduring anti-tumor memory that not only eliminates the primary tumor but also primes the immune system to combat metastatic tumors throughout the body.
Read more from sciencedaily.com